151 related articles for article (PubMed ID: 24900329)
1. Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist.
Xue CB; Feng H; Cao G; Huang T; Glenn J; Anand R; Meloni D; Zhang K; Kong L; Wang A; Zhang Y; Zheng C; Xia M; Chen L; Tanaka H; Han Q; Robinson DJ; Modi D; Storace L; Shao L; Sharief V; Li M; Galya LG; Covington M; Scherle P; Diamond S; Emm T; Yeleswaram S; Contel N; Vaddi K; Newton R; Hollis G; Friedman S; Metcalf B
ACS Med Chem Lett; 2011 Jun; 2(6):450-4. PubMed ID: 24900329
[TBL] [Abstract][Full Text] [Related]
2. Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2.
Xue CB; Wang A; Meloni D; Zhang K; Kong L; Feng H; Glenn J; Huang T; Zhang Y; Cao G; Anand R; Zheng C; Xia M; Han Q; Robinson DJ; Storace L; Shao L; Li M; Brodmerkel CM; Covington M; Scherle P; Diamond S; Yeleswaram S; Vaddi K; Newton R; Hollis G; Friedman S; Metcalf B
Bioorg Med Chem Lett; 2010 Dec; 20(24):7473-8. PubMed ID: 21036044
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a 4-Azetidinyl-1-thiazoyl-cyclohexane CCR2 Antagonist as a Development Candidate.
Zhang X; Hou C; Hufnagel H; Singer M; Opas E; McKenney S; Johnson D; Sui Z
ACS Med Chem Lett; 2012 Dec; 3(12):1039-44. PubMed ID: 24900425
[TBL] [Abstract][Full Text] [Related]
4. Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2.
Yang MG; Xiao Z; Zhao R; Tebben AJ; Wang B; Cherney RJ; Batt DG; Brown GD; Cvijic ME; Duncia JV; Gallela MA; Gardner DS; Khandelwal P; Malley MF; Pang J; Rose AV; Santella JB; Sarjeant AA; Xu S; Mathur A; Mandlekar S; Vuppugalla R; Zhao Q; Carter PH
ACS Med Chem Lett; 2021 Jun; 12(6):969-975. PubMed ID: 34141082
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
Buntinx M; Hermans B; Goossens J; Moechars D; Gilissen RA; Doyon J; Boeckx S; Coesemans E; Van Lommen G; Van Wauwe JP
J Pharmacol Exp Ther; 2008 Oct; 327(1):1-9. PubMed ID: 18599682
[TBL] [Abstract][Full Text] [Related]
6. Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist.
Xue CB; Wang A; Han Q; Zhang Y; Cao G; Feng H; Huang T; Zheng C; Xia M; Zhang K; Kong L; Glenn J; Anand R; Meloni D; Robinson DJ; Shao L; Storace L; Li M; Hughes RO; Devraj R; Morton PA; Rogier DJ; Covington M; Scherle P; Diamond S; Emm T; Yeleswaram S; Contel N; Vaddi K; Newton R; Hollis G; Metcalf B
ACS Med Chem Lett; 2011 Dec; 2(12):913-8. PubMed ID: 24900280
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.
Yang L; Butora G; Jiao RX; Pasternak A; Zhou C; Parsons WH; Mills SG; Vicario PP; Ayala JM; Cascieri MA; MacCoss M
J Med Chem; 2007 May; 50(11):2609-11. PubMed ID: 17461566
[TBL] [Abstract][Full Text] [Related]
8. Alkylsulfone-containing trisubstituted cyclohexanes as potent and bioavailable chemokine receptor 2 (CCR2) antagonists.
Cherney RJ; Mo R; Yang MG; Xiao Z; Zhao Q; Mandlekar S; Cvijic ME; Charo IF; Barrish JC; Decicco CP; Carter PH
Bioorg Med Chem Lett; 2014 Apr; 24(7):1843-5. PubMed ID: 24613378
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of INCB3344, a small molecule antagonist of human CCR2.
Shin N; Baribaud F; Wang K; Yang G; Wynn R; Covington MB; Feldman P; Gallagher KB; Leffet LM; Lo YY; Wang A; Xue CB; Newton RC; Scherle PA
Biochem Biophys Res Commun; 2009 Sep; 387(2):251-5. PubMed ID: 19576173
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a Potent and Orally Bioavailable Dual Antagonist of CC Chemokine Receptors 2 and 5.
Carter PH; Brown GD; Cherney RJ; Batt DG; Chen J; Clark CM; Cvijic ME; Duncia JV; Ko SS; Mandlekar S; Mo R; Nelson DJ; Pang J; Rose AV; Santella JB; Tebben AJ; Traeger SC; Xu S; Zhao Q; Barrish JC
ACS Med Chem Lett; 2015 Apr; 6(4):439-44. PubMed ID: 25893046
[TBL] [Abstract][Full Text] [Related]
11. Novel, orally bioavailable gamma-aminoamide CC chemokine receptor 2 (CCR2) antagonists.
Pasternak A; Marino D; Vicario PP; Ayala JM; Cascierri MA; Parsons W; Mills SG; Maccoss M; Yang L
J Med Chem; 2006 Aug; 49(16):4801-4. PubMed ID: 16884289
[TBL] [Abstract][Full Text] [Related]
12. Cloning and functional characterization of the 5'-flanking region of the human monocyte chemoattractant protein-1 receptor (CCR2) gene. Essential role of 5'-untranslated region in tissue-specific expression.
Yamamoto K; Takeshima H; Hamada K; Nakao M; Kino T; Nishi T; Kochi M; Kuratsu J; Yoshimura T; Ushio Y
J Biol Chem; 1999 Feb; 274(8):4646-54. PubMed ID: 9988701
[TBL] [Abstract][Full Text] [Related]
13. Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344.
Brodmerkel CM; Huber R; Covington M; Diamond S; Hall L; Collins R; Leffet L; Gallagher K; Feldman P; Collier P; Stow M; Gu X; Baribaud F; Shin N; Thomas B; Burn T; Hollis G; Yeleswaram S; Solomon K; Friedman S; Wang A; Xue CB; Newton RC; Scherle P; Vaddi K
J Immunol; 2005 Oct; 175(8):5370-8. PubMed ID: 16210643
[TBL] [Abstract][Full Text] [Related]
14. The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity.
Cumming JG; Bower JF; Waterson D; Faull A; Poyser PJ; Turner P; McDermott B; Campbell AD; Hudson J; James M; Winter J; Wood C
Bioorg Med Chem Lett; 2012 Jun; 22(12):3895-9. PubMed ID: 22608963
[TBL] [Abstract][Full Text] [Related]
15. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle.
Mirzadegan T; Diehl F; Ebi B; Bhakta S; Polsky I; McCarley D; Mulkins M; Weatherhead GS; Lapierre JM; Dankwardt J; Morgans D; Wilhelm R; Jarnagin K
J Biol Chem; 2000 Aug; 275(33):25562-71. PubMed ID: 10770925
[TBL] [Abstract][Full Text] [Related]
16. Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1/CC chemokine receptor 2-mediated inflammation.
Zhou X; Chen K; Lei H; Sun Z
J Am Soc Nephrol; 2015 Jan; 26(1):121-32. PubMed ID: 24904083
[TBL] [Abstract][Full Text] [Related]
17. Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists.
Cherney RJ; Brogan JB; Mo R; Lo YC; Yang G; Miller PB; Scherle PA; Molino BF; Carter PH; Decicco CP
Bioorg Med Chem Lett; 2009 Feb; 19(3):597-601. PubMed ID: 19131247
[TBL] [Abstract][Full Text] [Related]
18. Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines.
Tangirala RK; Murao K; Quehenberger O
J Biol Chem; 1997 Mar; 272(12):8050-6. PubMed ID: 9065478
[TBL] [Abstract][Full Text] [Related]
19. Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease.
Walters MJ; Wang Y; Lai N; Baumgart T; Zhao BN; Dairaghi DJ; Bekker P; Ertl LS; Penfold ME; Jaen JC; Keshav S; Wendt E; Pennell A; Ungashe S; Wei Z; Wright JJ; Schall TJ
J Pharmacol Exp Ther; 2010 Oct; 335(1):61-9. PubMed ID: 20660125
[TBL] [Abstract][Full Text] [Related]
20. Cloning and functional characterization of the rabbit C-C chemokine receptor 2.
Lu D; Yuan XJ; Evans RJ; Pappas AT; Wang H; Su EW; Hamdouchi C; Venkataraman C
BMC Immunol; 2005 Jul; 6():15. PubMed ID: 16001983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
